Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BeOne Medicines Ltd. Director's Dealing 2025

May 13, 2025

30073_dirs_2025-05-13_7009f4af-ac78-45fa-b0b1-f9f807de6393.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2025-05-09

Reporting Person: OYLER JOHN (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-05-09 Ordinary Shares M 4055415 $0.50 Acquired 10154040 Direct
2025-05-09 Ordinary Shares F 1990603 $17.85 Disposed 8163437 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-05-09 Share Option (Right to Buy) $0.50 M 4055415 Disposed 2025-07-19 Ordinary Shares (4055415) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 481533 Indirect
Ordinary Shares 7722480 Indirect
Ordinary Shares 28204115 Indirect
Ordinary Shares 9545000 Indirect
Ordinary Shares 102188 Indirect

Footnotes

F1: These shares were withheld to satisfy the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire July 19, 2025.

F2: These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.

F3: These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

F4: These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

F5: These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.

F6: These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.

F7: These securities vest over a five-year period as follows: 20% on July 19, 2016, and the remaining in 48 successive equal monthly installments, subject to continued service.